A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease (HESTIA3)
2020-07-04
عنوان الدراسة
A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease (HESTIA3)
داعم الدراسة
Astrazeneca
دواء الدراسة
Ticagrelor
رقم بروتوكول الدراسة
D5136C00009
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。